Sung Wook Jang,
Investigator,
National Institutes of Health (NIH)
Dr. Jang is currently a postdoctoral fellow with Dr. James Inglese at the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). He has continuously utilized tools of chemical biology to explore therapeutic avenues for a broad spectrum of disorders. His current research interest revolves around the strategic use of technology in assay development as part of the translational science focused on rare genetic diseases. These disorders are often neglected due to mechanistic complexity and a limited market hindering pharmaceutical company investments. Over the past years, he has been involved in a drug development program for inherited peripheral neuropathy called Charcot-Marie-Tooth (CMT) diseases at NIH in close partnership with a patient advocate community. His recent work represents an assay development and drug repurposing strategy for CMT as well as approaches to address fundamental issues in the use of sensitive reporters frequently plagued by their artifactual outcomes.
|
|
|